Veru receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Feb 25, 2025

VERU INC.

Nasdaq notified Veru on Aug 29, 2024 that common stock bid price was below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until Feb 25, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant by Feb 25, 2025, Veru may qualify for a second 180-day period if it meets other listing standards and intends to cure via reverse stock split.
Failure to regain compliance could lead to delisting from Nasdaq Capital Market.
Trading of VERU common stock continues unaffected during the cure period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.